Larson Financial Group’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Larson Financial Group’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-751	Closed	-$653	–	1772
2023 Q2	$653	Hold	751	–	–	﹤0.01%	1413
2023 Q1	$525	Hold	751	–	–	﹤0.01%	1408
2022 Q4	$616	Hold	751	–	–	﹤0.01%	1352
2022 Q3	$1K	Buy	+751	New	+$1.2K	﹤0.01%	1274

Larson Financial Group's SURF Position: Q3 2023 in Review

Larson Financial Group sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2023, closing a stake of 751 shares — an estimated $653 sold.

Larson Financial Group first reported a position in SURF in Q3 2022 and held it in 4 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold SURF as of Q3 2023.

Larson Financial Group reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Larson Financial Group sold 751 Surface Oncology, Inc. Common Stock shares in Q3 2023, an estimated $653.
Larson Financial Group first reported a position in Surface Oncology, Inc. Common Stock in Q3 2022 and held it in 4 quarters.
Larson Financial Group's Surface Oncology, Inc. Common Stock position peaked at $1K in Q3 2022.
0 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2023.

Based on Larson Financial Group's 13F filing for Q3 2023, filed 3 Nov 2023.